Senate Bill 211

Actions
Last Action 02/19/26: to Committee on Committees (S)
Title AN ACT relating to coverage for prescription drugs.
Bill Documents Introduced
Fiscal Impact Statements Actuarial Analysis
Health Mandate
Local Mandate
State Employee Health Plan Impact
Bill Request Number 2131
Sponsor C. Richardson
Summary of Original Version Create a new section of Subtitle 17A of KRS Chapter 304 to require health plans to include a generic drug or biosimilar on the plan's formulary under specified circumstances; define terms; establish cost-sharing requirements when a generic drug or biosimilar is required to be placed on the health plan's formulary; prohibit a health plan from imposing any prior authorization, step therapy, or other limitation on coverage for a generic drug or biosimilar required to be placed on the health plan's formulary or imposing any restriction on a pharmacist or pharmacy that makes it more difficult for the insured to obtain coverage or access to the generic drug or biosimilar compared to the reference drug or product; amend KRS 304.17C-125, 164.2871, and 18A.225 to require limited health service benefit plans, self-insured group health plans offered by a state postsecondary education institution, and the state employee health plan to comply with the requirements for generic drugs and biosimilars; direct that the Act applies to health plans issued or renewed on or after January 1, 2027; EFFECTIVE, January 1, 2027.
Index Headings of Original Version Drugs And Medicines - Generic drugs and biosimilars, insurance, formulary placement
Education, Higher - Self-insured group health plan, generic drugs and biosimilars, formulary placement
Effective Dates, Delayed - Generic drugs and biosimilars, insurance, formulary placement, January 1, 2027
Health And Medical Services - Generic drugs and biosimilars, insurance, formulary placement
Insurance, Health - Generic drugs and biosimilars, formulary placement
Pharmacists - Generic drugs and biosimilars, insurance, formulary placement
State Employees - Health plan, generic drugs and biosimilars, formulary placement

Actions

Top
02/19/26
  • introduced in Senate
  • to Committee on Committees (S)


Last updated: 3/9/2026 7:15 PM (EDT)